CAD 0.07
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 223.33 Thousand CAD | 105.64% |
2022 | -3.96 Million CAD | 31.12% |
2021 | -5.75 Million CAD | 4.01% |
2020 | -5.99 Million CAD | 41.13% |
2019 | -10.18 Million CAD | -361.92% |
2018 | -2.2 Million CAD | -288.83% |
2017 | -566.86 Thousand CAD | -3544.46% |
2016 | -15.55 Thousand CAD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q3 | -317.26 Thousand CAD | 68.65% |
2024 Q2 | -1.01 Million CAD | -861.83% |
2024 Q1 | 132.82 Thousand CAD | -65.74% |
2023 Q2 | -32.83 Thousand CAD | 94.38% |
2023 Q1 | -584.55 Thousand CAD | 37.89% |
2023 FY | 223.33 Thousand CAD | 105.64% |
2023 Q4 | 387.64 Thousand CAD | -7.68% |
2023 Q3 | 419.87 Thousand CAD | 1378.74% |
2022 Q4 | -941.18 Thousand CAD | 15.53% |
2022 Q3 | -1.11 Million CAD | -53.59% |
2022 Q2 | -725.46 Thousand CAD | 38.61% |
2022 Q1 | -1.18 Million CAD | 39.74% |
2022 FY | -3.96 Million CAD | 31.12% |
2021 FY | -5.75 Million CAD | 4.01% |
2021 Q2 | -1.18 Million CAD | -30.45% |
2021 Q3 | -945.61 Thousand CAD | 20.48% |
2021 Q4 | -1.96 Million CAD | -107.38% |
2021 Q1 | -911.51 Thousand CAD | 59.83% |
2020 Q4 | -2.26 Million CAD | -122.28% |
2020 Q1 | -1.32 Million CAD | 35.61% |
2020 Q2 | -1.34 Million CAD | -1.74% |
2020 FY | -5.99 Million CAD | 41.13% |
2020 Q3 | -1.02 Million CAD | 24.02% |
2019 Q3 | -1.48 Million CAD | 66.7% |
2019 FY | -10.18 Million CAD | -361.92% |
2019 Q4 | -2.05 Million CAD | -37.68% |
2019 Q2 | -4.47 Million CAD | -3737.23% |
2019 Q1 | -116.57 Thousand CAD | -192.51% |
2018 Q1 | -21.02 Thousand CAD | 52.05% |
2018 Q2 | -191.42 Thousand CAD | -810.56% |
2018 FY | -2.2 Million CAD | -288.83% |
2018 Q3 | -18.99 Thousand CAD | 90.08% |
2018 Q4 | -39.85 Thousand CAD | -109.81% |
2017 FY | -566.86 Thousand CAD | -3544.46% |
2017 Q3 | -22.97 Thousand CAD | 0.0% |
2017 Q4 | -43.84 Thousand CAD | -90.85% |
2016 FY | -15.55 Thousand CAD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Aion Therapeutic Inc. | -6.28 Million CAD | 103.552% |
Ayurcann Holdings Corp. | -3.96 Million CAD | 105.629% |
Blueberries Medical Corp. | -1.63 Million CAD | 113.656% |
The BC Bud Corporation | -1.22 Million CAD | 118.245% |
BioNxt Solutions Inc. | -7.72 Million CAD | 102.892% |
CordovaCann Corp. | -6.88 Million CAD | 103.244% |
Christina Lake Cannabis Corp. | -4.13 Million CAD | 105.405% |
Captor Capital Corp. | -11.38 Million CAD | 101.962% |
City View Green Holdings Inc. | -2.44 Million CAD | 109.121% |
1CM Inc. | -913.85 Thousand CAD | 124.439% |
Global Hemp Group Inc. | -2.58 Million CAD | 108.655% |
Greenway Greenhouse Cannabis Corporation | -4.72 Million CAD | 104.729% |
IM Cannabis Corp. | -9.49 Million CAD | 102.351% |
Lobe Sciences Ltd. | -4.7 Million CAD | 104.744% |
Maple Leaf Green World Inc. | -1.09 Million CAD | 120.461% |
Mountain Valley MD Holdings Inc. | -7.67 Million CAD | 102.912% |
Ovation Science Inc. | -813.14 Thousand CAD | 127.465% |
Pharmadrug Inc. | -13.2 Million CAD | 101.692% |
Captiva Verde Wellness Corp. | -6.08 Million CAD | 103.67% |
RAMM Pharma Corp. | -7.72 Million CAD | 102.893% |
RIV Capital Inc. | -106.76 Million CAD | 100.209% |
Revive Therapeutics Ltd. | -5.61 Million CAD | 103.975% |
Red White & Bloom Brands Inc. | -138.89 Million CAD | 100.161% |
SLANG Worldwide Inc. | -19.36 Million CAD | 101.153% |
1933 Industries Inc. | -13.36 Million CAD | 101.671% |
Red Light Holland Corp. | -7.62 Million CAD | 102.928% |
Top Strike Resources Corp. | -1.72 Million CAD | 112.984% |
Xebra Brands Ltd. | -1.95 Million CAD | 111.41% |
Adastra Holdings Ltd. | -3.54 Million CAD | 106.301% |